The role of different biomarkers (DNA, PCNA, apoptosis and karyotype) in prognostic evaluation of superficial transitional cell bladder carcinoma

被引:0
作者
Lavezzi, AM
Biondo, B
Cazzullo, A
Giordano, F
Pallotti, F
Turconi, P
Matturri, L
机构
[1] Univ Milan, Inst Pathol, I-20122 Milan, Italy
[2] Vimercate Hosp Milan, Dept Pathol, Milan, Italy
关键词
bladder carcinoma; superficial transitional cell-biomarkers; prognosis; DNA; PCNA; apoptosis; karyotype;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In order to clarify the variable behaviour of transitional cell bladder caucinomas (TCBC) with same clinico-pathologic pattern, we investigated the prognostic significance of various biomarkers (PCNA, DNA, apoptosis, karyotype). Materials and Methods: We studied 177 superficial TCBC (stage TI) undergoing transurethral resection (TUR). Analysis of biological indicators was performed on serial paraffin sections: DNA by static cytometry, karyotype by fluorescence in situ hybridisation (FISH), PCNA and apoptosis by immunohistochemistry. Results: The most salient results are represented by prevalence of diploidy (56%), a mean PCNA labeling index (PCNA-LI) of 8.2%, nonrandom trisomies and tetrasomies of chromosome 7, and a high presence of apoptosis (in 72% of cases). These data were not related to histological grading. Multivariate analysis showed that only PCNA-LI is a an independent prognastic marker for patient survival (p= 0.01). Besides, we observed a worse prognosis in the presence of both very high PCNA indices and low or absent apoptosis. Conclusions: The results of this study suggest that tumor prognostic potential in TCBC should be evaluated on the basis of the association between PCNA cell kinetics and cell apoptosis information.
引用
收藏
页码:1279 / 1284
页数:6
相关论文
共 28 条
[1]  
BABU VR, 1987, CANCER RES, V47, P6800
[2]   RETROSPECTIVE STUDY OF PROGNOSTIC IMPORTANCE OF DNA FLOW-CYTOMETRY OF URINARY-BLADDER CARCINOMA [J].
BLOMJOUS, CEM ;
SCHIPPER, NW ;
BAAK, JPA ;
VANGALEN, EM ;
DEVOOGT, HJ ;
MEYER, CJLM .
JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (01) :21-25
[3]   CYCLIN PCNA IS THE AUXILIARY PROTEIN OF DNA POLYMERASE-DELTA [J].
BRAVO, R ;
FRANK, R ;
BLUNDELL, PA ;
MACDONALDBRAVO, H .
NATURE, 1987, 326 (6112) :515-517
[4]  
CAMPANELLA R, 1992, EUR UROL, V21, P58
[5]  
CATALONA WJ, 1992, CAMPBELLS UROLOGY, P1094
[7]   Expression and prognostic value of proliferating cell nuclear antigen in transitional cell carcinoma of the urinary bladder [J].
Chen, G ;
Lin, MS ;
Li, RC .
UROLOGICAL RESEARCH, 1997, 25 (01) :25-29
[8]   ACCUMULATION OF NUCLEAR P53 AND TUMOR PROGRESSION IN BLADDER-CANCER [J].
ESRIG, D ;
ELMAJIAN, D ;
GROSHEN, S ;
FREEMAN, JA ;
STEIN, JP ;
CHEN, SC ;
NICHOLS, PW ;
SKINNER, DG ;
JONES, PA ;
COTE, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (19) :1259-1264
[9]   PROLIFERATING CELL NUCLEAR ANTIGEN CYCLIN IN HUMAN TRANSITIONAL-CELL CARCINOMA [J].
HATTORI, K ;
UCHIDA, K ;
AKAZA, H ;
KOISO, K ;
NEMOTO, R ;
HARADA, M .
BRITISH JOURNAL OF UROLOGY, 1995, 75 (02) :162-166
[10]   Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: Association with tumor progression [J].
King, ED ;
Matteson, J ;
Jacobs, SC ;
Kyprianou, N .
JOURNAL OF UROLOGY, 1996, 155 (01) :316-320